Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
E. D. Nosyreva, Kristen L. Szabla, Anita E. Autry, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 16, pp. 6990-7002
Open Access | Times Cited: 259

Showing 1-25 of 259 citing articles:

Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 895
BDNF – a key transducer of antidepressant effects
Carl Björkholm, Lisa M. Monteggia
Neuropharmacology (2015) Vol. 102, pp. 72-79
Open Access | Times Cited: 825
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport, Linda L. Carpenter, William M. McDonald, et al.
American Journal of Psychiatry (2015) Vol. 172, Iss. 10, pp. 950-966
Open Access | Times Cited: 543
The mechanisms and functions of spontaneous neurotransmitter release
Ege T. Kavalali
Nature reviews. Neuroscience (2014) Vol. 16, Iss. 1, pp. 5-16
Closed Access | Times Cited: 469
BDNF signaling in context: From synaptic regulation to psychiatric disorders
Camille S. Wang, Ege T. Kavalali, Lisa M. Monteggia
Cell (2021) Vol. 185, Iss. 1, pp. 62-76
Open Access | Times Cited: 355
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Eero Ċastrén, Lisa M. Monteggia
Biological Psychiatry (2021) Vol. 90, Iss. 2, pp. 128-136
Open Access | Times Cited: 352
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa‐Mattioli, Lisa M. Monteggia
Nature Neuroscience (2013) Vol. 16, Iss. 11, pp. 1537-1543
Closed Access | Times Cited: 343
The Role of BDNF on Neural Plasticity in Depression
Tao Yang, Zheng Nie, Haifeng Shu, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 305
An excitatory synapse hypothesis of depression
Scott M. Thompson, Angy J. Kallarackal, Mark D. Kvarta, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 5, pp. 279-294
Open Access | Times Cited: 250
Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
Erinn Gideons, Ege T. Kavalali, Lisa M. Monteggia
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 23, pp. 8649-8654
Open Access | Times Cited: 213
Spontaneous and Evoked Release Are Independently Regulated at Individual Active Zones
Jan E. Melom, Yulia Akbergenova, Jeffrey P. Gavornik, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 44, pp. 17253-17263
Open Access | Times Cited: 202
Ketamine: NMDA Receptors and Beyond
Charles F. Zorumski, Yukitoshi Izumi, Steven Mennerick
Journal of Neuroscience (2016) Vol. 36, Iss. 44, pp. 11158-11164
Open Access | Times Cited: 198
Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
Oliver H. Miller, Jacqueline Moran, Benjamin J. Hall
Neuropharmacology (2015) Vol. 100, pp. 17-26
Closed Access | Times Cited: 191
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova, Anthony G. Phillips, Yu Tian Wang
Journal of Psychiatry and Neuroscience (2017) Vol. 42, Iss. 4, pp. 222-229
Open Access | Times Cited: 187
Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
Allie J. Widman, Lori L. McMahon
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 13
Open Access | Times Cited: 181
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 180
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 166
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 164
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 164
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 155
Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders
Ege T. Kavalali, Lisa M. Monteggia
Neuron (2020) Vol. 106, Iss. 5, pp. 715-726
Open Access | Times Cited: 148
Mechanisms of ketamine and its metabolites as antidepressants
Evan Hess, Lace M. Riggs, Michael Michaelides, et al.
Biochemical Pharmacology (2021) Vol. 197, pp. 114892-114892
Open Access | Times Cited: 116
Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
John H. Krystal, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 41-50
Open Access | Times Cited: 87
The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 72
Ketamine: Mechanisms and Relevance to Treatment of Depression
Ji‐Woon Kim, Kanzo Suzuki, Ege T. Kavalali, et al.
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 129-143
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top